Favorites Sign in
  1. Home
  2. Companies
  3. Stock Biohaven Pharmaceutical Holding Company Ltd.
Biohaven Pharmaceutical Holding Company Ltd. logo

Biohaven Pharmaceutical Holding Company Ltd. BHVN

$ 13.88 -8.98%
report update icon

Quarterly report 2022-Q2
added 06-06-2026

Country

 usaUSA

IPO year

 2017

Industry

 Biotechnology

Stock Exchange

 NYSE

Shares

 64.7 M

Market Cap[1]

 $ 898 M

EBITDA (LTM)

 -

P/E (LTM)

 -

P/S (LTM)

 -

EPS (LTM)

 -

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Auris Medical Holding Ltd. Auris Medical Holding Ltd.
EARS
 		- -1.77 % $ 39.2 M Nasdaq Capital Market bermudaBermuda
Dicerna Pharmaceuticals, Inc. Dicerna Pharmaceuticals, Inc.
DRNA
 		- 0.34 % $ 2.98 B Nasdaq Global Select Market,SPB usaUSA
ERYTECH Pharma S.A. ERYTECH Pharma S.A.
ERYP
 		- 1.3 % $ 27.7 M Nasdaq Global Select Market franceFrance
22nd Century Group 22nd Century Group
XXII
 		$ 1.89 -22.41 % $ 348 K NYSE American usaUSA
GW Pharmaceuticals plc GW Pharmaceuticals plc
GWPH
 		- - $ 6.81 B Nasdaq Global Select Market britainBritain
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
 		- - $ 1.7 B Nasdaq Global Select Market usaUSA
Liminal BioSciences Liminal BioSciences
LMNL
 		- - $ 256 M Nasdaq Global Market canadaCanada
argenx SE argenx SE
ARGX
 		$ 894.61 -3.95 % $ 54.8 B Nasdaq Global Select Market niderlandNiderland
XBiotech XBiotech
XBIT
 		$ 1.89 -3.08 % $ 57.6 M Nasdaq Global Select Market usaUSA
Neos Therapeutics, Inc. Neos Therapeutics, Inc.
NEOS
 		- -2.54 % $ 57.2 M Nasdaq Global Market usaUSA
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.
ODT
 		- -3.18 % $ 58.5 M Nasdaq Global Select Market usaUSA
Orphazyme A/S Orphazyme A/S
ORPH
 		- -2.25 % $ 31.3 M Nasdaq Global Select Market danmarkDanmark
Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals plc
OSMT
 		- -10.74 % $ 89.9 M Nasdaq Global Select Market usaUSA
Pandion Therapeutics, Inc. Pandion Therapeutics, Inc.
PAND
 		- - $ 1.77 B Nasdaq Global Select Market usaUSA
Xenetic Biosciences Xenetic Biosciences
XBIO
 		$ 1.89 -5.97 % $ 3.22 M Nasdaq Capital Market usaUSA
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
VRTX
 		$ 542.93 -1.11 % $ 139 B Nasdaq Global Select Market,SPB usaUSA
Translate Bio, Inc. Translate Bio, Inc.
TBIO
 		- - $ 2.81 B Nasdaq Global Select Market,SPB usaUSA
Trillium Therapeutics Inc. Trillium Therapeutics Inc.
TRIL
 		- - $ 1.94 B Nasdaq Capital Market canadaCanada
Exicure Exicure
XCUR
 		$ 0.89 -10.34 % $ 5.6 M Nasdaq Capital Market usaUSA
Urovant Sciences Ltd. Urovant Sciences Ltd.
UROV
 		- - $ 532 M Nasdaq Global Select Market britainBritain
Acceleron Pharma Inc. Acceleron Pharma Inc.
XLRN
 		- - $ 10.9 B Nasdaq Global Market,SPB usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
 		- 0.52 % $ 821 M Nasdaq Global Select Market danmarkDanmark
Zogenix, Inc. Zogenix, Inc.
ZGNX
 		- -4.97 % $ 664 M Nasdaq Global Market,SPB usaUSA
Yunhong International Yunhong International
ZGYH
 		- 0.10 % $ 92.2 M Nasdaq Capital Market chinaChina
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
ZIOP
 		- -7.58 % $ 264 M Nasdaq Global Select Market usaUSA
Xenon Pharmaceuticals Xenon Pharmaceuticals
XENE
 		$ 37.65 -3.93 % $ 2.98 B Nasdaq Global Select Market canadaCanada
Leap Therapeutics Leap Therapeutics
LPTX
 		- 368.57 % $ 41.9 M Nasdaq Global Market usaUSA
Zymeworks Zymeworks
ZYME
 		$ 28.83 -6.82 % $ 1.49 B NYSE canadaCanada
Adial Pharmaceuticals Adial Pharmaceuticals
ADIL
 		$ 3.15 -35.42 % $ 2.11 M Nasdaq Capital Market usaUSA
ADMA Biologics ADMA Biologics
ADMA
 		$ 13.2 25.91 % $ 3.15 B Nasdaq Global Market usaUSA
Cortexyme Cortexyme
CRTX
 		- -1.05 % $ 67.1 M Nasdaq Global Select Market,SPB usaUSA
Burford Capital Limited Burford Capital Limited
BUR
 		$ 3.94 -5.52 % $ 863 M NYSE britainBritain
Daré Bioscience Daré Bioscience
DARE
 		$ 0.62 -3.5 % $ 6.93 M Nasdaq Capital Market usaUSA
Fate Therapeutics Fate Therapeutics
FATE
 		$ 1.86 -11.24 % $ 221 M Nasdaq Global Market,SPB usaUSA
Greenwich LifeSciences Greenwich LifeSciences
GLSI
 		$ 14.63 -10.55 % $ 198 M Nasdaq Capital Market usaUSA
Halozyme Therapeutics Halozyme Therapeutics
HALO
 		$ 123.1 -5.55 % $ 14.8 B Nasdaq Global Select Market,SPB usaUSA
Hutchison China MediTech Limited Hutchison China MediTech Limited
HCM
 		$ 14.15 1.65 % $ 12.1 B Nasdaq Global Select Market chinaChina
Aptorum Group Limited Aptorum Group Limited
APM
 		- - $ 5.72 M Nasdaq Global Select Market chinaChina
iBio iBio
IBIO
 		$ 0.73 -8.74 % $ 76 M NYSE American usaUSA
Kodiak Sciences Kodiak Sciences
KOD
 		$ 90.95 -7.67 % $ 4.84 B Nasdaq Global Market,SPB usaUSA
Karyopharm Therapeutics Karyopharm Therapeutics
KPTI
 		$ 0.06 -15.5 % $ 656 Nasdaq Global Select Market usaUSA
FSD Pharma FSD Pharma
HUGE
 		- 5743.5 % $ 69.7 M Nasdaq Capital Market canadaCanada
BioAtla BioAtla
BCAB
 		$ 1.74 0.64 % $ 102 M Nasdaq Global Select Market usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
 		- - $ 3.85 B Nasdaq Capital Market usaUSA
UroGen Pharma Ltd. UroGen Pharma Ltd.
URGN
 		$ 25.27 -12.07 % $ 1.22 B Nasdaq Global Select Market israelIsrael
Catalyst Biosciences Catalyst Biosciences
CBIO
 		$ 12.93 -6.44 % $ 1.16 B Nasdaq Capital Market usaUSA
ARCA biopharma ARCA biopharma
ABIO
 		- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
Acasti Pharma Acasti Pharma
ACST
 		- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
ADiTx Therapeutics ADiTx Therapeutics
ADTX
 		- - $ 374 Nasdaq Capital Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.